Alivus Life Sciences Ltd. engages in the provision of development and manufacture of non-commoditized active pharmaceutical ingredients. It operates through the Within India and Outside India geographical segments. Its products focus on chronic therapeutic areas, including cardiovascular disease, central nervous system disease, pain management, and diabetes. The company was founded on June 23, 2011 and is headquartered in Mumbai, India.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
3,936
Frequently Asked Questions
What is Market Cap of Alivus Life Sciences Ltd.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Alivus Life Sciences Ltd. market cap is 113.19B.
What is the 52-week high for Alivus Life Sciences Ltd.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Alivus Life Sciences Ltd. 52 week high is 1,335.10 as of September 05, 2025.
What is the 52-week low for Alivus Life Sciences Ltd.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Alivus Life Sciences Ltd. 52 week low is 850.00 as of September 05, 2025.
What is Alivus Life Sciences Ltd. stock price today?
Alivus Life Sciences Ltd. stock price today is 924.90.
What was Alivus Life Sciences Ltd. stock price yesterday?
Alivus Life Sciences Ltd. stock price yesterday was 926.25.
What is the PE ratio of Alivus Life Sciences Ltd.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Alivus Life Sciences Ltd.’s P/E ratio is 22.82.
What is the Price-to-Book ratio of Alivus Life Sciences Ltd.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Alivus Life Sciences Ltd. P/B ratio is 4.0144.
What is the 50-day moving average of Alivus Life Sciences Ltd.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Alivus Life Sciences Ltd. 50-day moving average is 992.78.
How many employess does Alivus Life Sciences Ltd. has?